000 | 01885 a2200553 4500 | ||
---|---|---|---|
005 | 20250515180344.0 | ||
264 | 0 | _c20100126 | |
008 | 201001s 0 0 eng d | ||
022 | _a1439-7609 | ||
024 | 7 |
_a10.1007/s10165-009-0199-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKuwana, Masataka | |
245 | 0 | 0 |
_aLong-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis. _h[electronic resource] |
260 |
_bModern rheumatology _c2009 |
||
300 |
_a530-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
650 | 0 | 4 | _aAtorvastatin |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aCell Separation |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aE-Selectin _xblood |
650 | 0 | 4 |
_aEndothelial Cells _xcytology |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xblood |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aFluorescent Antibody Technique |
650 | 0 | 4 | _aHealth Status |
650 | 0 | 4 |
_aHeptanoic Acids _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoprecipitation |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
650 | 0 | 4 |
_aRaynaud Disease _xdrug therapy |
650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aStem Cells _xcytology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xblood |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xblood |
700 | 1 | _aOkazaki, Yuka | |
700 | 1 | _aKaburaki, Junichi | |
773 | 0 |
_tModern rheumatology _gvol. 19 _gno. 5 _gp. 530-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10165-009-0199-4 _zAvailable from publisher's website |
999 |
_c19005698 _d19005698 |